• Jump to main navigation
  • Jump to content
U of U Health
  • Find A Doctor Find A U of U Health Doctor
  • Services All U of U Health Services
  • Locations All U of U Health Locations
  • For Patients & Visitors For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart

Lehman, Christopher M., MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English

Dr. Lehman is the Medical Director of the University Hospital, University Neuropsychiatric Institute and South Jordan Health Center Clinical Laboratories and is a clinical professor of pathology at the University of Utah School of Medicine. Dr. Lehman received his MD from the University of Utah and is board certified in clinical pathology, blood banking, and transfusion medicine by the American Board of Pathology. Dr. Lehman is a member of several professional medical organizations and is involved in laboratory accreditation and quality improvement activities nationally. His research interests include optimal application of laboratory testing to patient care and laboratory quality improvement.

Dr. Lehman is the Medical Director of the University Hospital, University Neuropsychiatric Institute and South Jordan Health Center Clinical Laboratories and is a Clinical Professor of Pathology at the University of Utah School of Medicine. Dr. Lehman received his MD from the University of Utah and is board certified in clinical pathology, blood banking, and transfusion medicine by the American Board of Pathology. Dr. Lehman is a member of several professional medical organizations and is involved in laboratory accreditation and quality improvement activities nationally.

Clinical Locations

University Hospital
Pathology

801-585-6877

50 N Medical Dr
Salt Lake City, UT  84132
Map

Specialties

  • Pathology

Board Certification and Academic Information

Academic Departments Pathology - Professor (Clinical)
Academic Divisions Clinical Pathology
Board Certification American Board of Pathology (Sub: Blood Banking/Transfusion Medicine)
American Board of Pathology (Clinical Path)

Dr. Lehman is the Medical Director of the University Hospital, University Neuropsychiatric Institute and South Jordan Health Center Clinical Laboratories and is a clinical professor of pathology at the University of Utah School of Medicine. Dr. Lehman received his MD from the University of Utah and is board certified in clinical pathology, blood banking, and transfusion medicine by the American Board of Pathology. Dr. Lehman is a member of several professional medical organizations and is involved in laboratory accreditation and quality improvement activities nationally. His research interests include optimal application of laboratory testing to patient care and laboratory quality improvement.

Dr. Lehman is the Medical Director of the University Hospital, University Neuropsychiatric Institute and South Jordan Health Center Clinical Laboratories and is a Clinical Professor of Pathology at the University of Utah School of Medicine. Dr. Lehman received his MD from the University of Utah and is board certified in clinical pathology, blood banking, and transfusion medicine by the American Board of Pathology. Dr. Lehman is a member of several professional medical organizations and is involved in laboratory accreditation and quality improvement activities nationally.

Academic Locations

Emma Eccles Jones Research Building

801-585-6877

15 North Medical Drive East
Pathology Department, 2100
Salt Lake City, UT  84112

Board Certification and Academic Information

Academic Departments Pathology - Professor (Clinical)
Academic Divisions Clinical Pathology
Board Certification American Board of Pathology (Sub: Blood Banking/Transfusion Medicine)
American Board of Pathology (Clinical Path)

Education History

Fellowship University of Minnesota Hospitals

Fellow
Residency George Washington University
Clinical Pathology
Resident
Internship George Washington University
Pathology
Intern
Graduate Training University of Utah School of Medicine
Anatomy
Professional Medical University of Utah Hospital School of Medicine
Medicine
M.D.
Undergraduate University of Massachusetts
Zoology
B.S.

Selected Publications - Journal Articles

Journal Article

  1. Adams A, Straseski JA, Lehman CM, Pearson LN (2019 Apr 8). Peritoneal and Pleural Fluid Chemistry Measurements Performed on Three Chemistry Platforms. Lab Med, 50(2), 145-149.
  2. Lehman CM, Pearson L, Salmond J, Raphael K, Schmidt RL (2019 Apr 8). A Reflex Protocol for Creatinine Testing Reduces Costs and Maintains Patient Safety. Lab Med, 50(2), 202-207.
  3. Alcorn K, Ramsey G, Souers R, Lehman CM (2017 Mar). Appropriateness of Plasma Transfusion: A College of American Pathologists Q-Probes Study of Guidelines, Waste, and Serious Adverse Events. Arch Pathol Lab Med, 141(3), 396-401.
  4. Barakauskas VE, Bradshaw TA, Smith LD, Lehman CM, Johnson-Davis KL (2016 Aug). Process Optimization to Improve Immunosuppressant Drug Testing Turnaround Time. Am J Clin Pathol, 146(2), 182-90.
  5. Schmidt RL, Straseski JA, Raphael KL, Adams AH, Lehman CM (2015). A Risk Assessment of the Jaffe vs Enzymatic Method for Creatinine Measurement in an Outpatient Population. PLoS ONE, 10(11), e0143205.
  6. Howanitz PJ, Lehman CM, Jones BA, Meier FA, Horowitz GL (2015 Aug). Practices for Identifying and Rejecting Hemolyzed Specimens Are Highly Variable in Clinical Laboratories. Arch Pathol Lab Med, 139(8), 1014-9.
  7. Howanitz PJ, Lehman CM, Jones BA, Meier FA, Horowitz GL (2015 Jul). Clinical Laboratory Quality Practices When Hemolysis Occurs. Arch Pathol Lab Med, 139(7), 901-6.
  8. Ramsey G, Wagar EA, Grimm EE, Friedberg RC, Souers RJ, Lehman CM (2015 Mar). Red blood cell transfusion practices: a College of American Pathologists Q-Probes study of compliance with audit criteria in 128 hospitals. Arch Pathol Lab Med, 139(3), 351-5.
  9. Schmidt RL, Kordy MA, Genzen JR, Straseski JA, Greene DN, Lehman CM (2015 Feb 2). A mathematical procedure to estimate the impact of a change in method on discordance or misclassification at a decision limit in laboratory method comparison studies. Clin Chim Acta, 440, 23-30.
  10. Lehman CM, Howanitz PJ, Souers R, Karcher DS (2014 Jun). Utility of repeat testing of critical values: a Q-probes analysis of 86 clinical laboratories. Arch Pathol Lab Med, 138(6), 788-93.
  11. Karcher DS, Lehman CM (2014 Aug). Clinical consequences of specimen rejection: a College of American Pathologists Q-Probes analysis of 78 clinical laboratories. Arch Pathol Lab Med, 138(8), 1003-8.
  12. Volmar KE, Wilkinson DS, Wagar EA, Lehman CM (). Utilization of Stat Test Priority in the Clinical Laboratory. Arch Pathol Lab Med, 137(2), 220-27.
  13. Johnson-Davis KL, Thompson CD, Clark CJ, McMillin GA, Lehman CM (2012 Jun). Method comparison of the Ortho Vitros Fusion 5,1 chemistry analyzer and the Roche COBAS Integra 400 for urine drug screen testing in the emergency department. J Anal Toxicol, 36(5), 345-8.
  14. Furtado LV, Lehman CM, Thompson C, Grenache DG (2012 Feb). Should the qualitative serum pregnancy test be considered obsolete? Am J Clin Pathol, 137(2), 194-202.
  15. Dina N Greene, Christopher M Lehman, and Gwendolyn A McMillin (). Evaluation of the Integrated E-Z Split Key® Cup II for rapid detection of 12 drug classesin urine. J Anal Toxicol, 35(1), 46-53.
  16. Smock KJ, Crist RA, Hansen SJ, Rodgers GM, Lehman CM (In Press). Discard tubes are not necessary when drawing samples for specialized coagulation testing. Blood Coagul Fibrinolysis, 21(3), 279-282.
  17. Grimm E, Friedberg R, Wilkinson DS, AnBuchon JP, Souers R, Lehman CM (In Press). Blood bank safety practices – a Q-Probes analysis of 122 clinical laboratories. Arch Pathol Lab Med, 134(8), 1108-1115.
  18. Bentley MJ, Lehman CM, Blaylock RC, Wilson AR, Rodgers GM (In Press). The Utility of Patient Characteristics in Predicting Severe ADAMTS13 Deficiency and Response to Plasma Exchange. Transfusion, 50(8), 1654-1664.
  19. Tandar A, Lehman CM, Rodgers GM, Meredith KG, Muhlestein JB, Garry WH, Michaels AD, Lee HR (11/2007). Activation of coagulation during routine diagnostic coronary angiography. EuroIntervention, 3, 345-49.
  20. Lehman CM, Rettmann JA, Wilson LW, Markewitz BA (2006 Sep). Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin. Am J Clin Pathol, 126(3), 416-21.
  21. Lehman CM, Wilson LW, Rodgers GM (2004 Aug). Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation. Am J Clin Pathol, 122(2), 178-84.
  22. Ford CD, Lehman CM, Strupp A, Kelley L (2002). A comparison of CD34+ cell collection efficiency on the Cobe Spectra and Fenwall CS-3000 Plus. J Clin Apheresis, 17(1), 17-20.
  23. Ford CD, Greenwood J, Strupp A, Lehman CM (2002 Jul). Change in CD34+ cell concentration during peripheral blood progenitor cell collection: effects on collection efficiency and efficacy. Transfusion, 42(7), 904-11.
  24. Lehman CM, Blaylock RC, Alexander DP, Rodgers GM (2001). Discontinuation of the bleeding time test without detectable adverse clinical impact. Clin Chem, 47(7), 1204-11.
  25. Roberts WL, Fontenot JD, Lehman CM (2000 Apr). Overestimation of hemoglobin in a patient with an IgA-kappa monoclonal gammopathy. Arch Path, 124(4), 616-8.
  26. Ford CD, Pace N, Lehman C (1998 Nov-Dec). Factors affecting the efficiency of collection of CD34-positive peripheral blood cells by a blood cell separator. Transfusion, 38(11-12), 1046-50.
  27. Ferreira-Gonzalez A, Fisher LM, Lehman CM, Langley MH, Lofland DH, Xia Q, Nguyen NX, Modesto D, Willoughby JB, Wilkinson DS, Garrett CT (1997). Detection of a common mutation in factor V gene responsible for resistance to activate protein C causing predisposition to thrombosis. J Clin Lab Anal, 11(6), 328-35.
  28. Lehman CM, Sarago C, Nasim S, Comerford J, Karcher DS, Garrett CT (1995 Feb). Comparison of PCR with southern hybridization for the routine detection of immunoglobulin heavy chain gene rearrangements. Am J Clin Pathol, 103(2), 171-6.
  29. Alkan S, Lehman C, Sarago C, Sidawy MK, Karcher DS, Garrett CT (1995 Mar). Polymerase chain reaction detection of immunoglobulin gene rearrangement and bcl-2 translocation in archival glass slides of cytologic material. Diagn Mol Pathol, 4(1), 25-31.
  30. Steen PD, McGregor JR, Lehman CM, Samlowski WE (1989 Dec 15). Changes in homing receptor expression on murine lymphokine-activated killer cells during IL-2 exposure. J Immunol, 143(12), 4324-30.
  31. Cheng WY, Ridinger DN, Lehman CM, Puryear RL, Dethlefsen LA (1989 Oct). The physiological state as a modifier of radiation-induced cytotoxicity in heterogeneous murine tumor cells growing in vitro. Int J Radiat Biol, 56(4), 463-83.
  32. Dethlefsen LA, Lehman CM, Biaglow JE, Peck VM (1988 May). Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells. Radiat Res, 114(2), 215-24.
  33. Dethlefsen LA, Riley RM, Lehman CM (1984 Oct). Delayed enhanced effects of Adriamycin on the X-irradiation-induced gastrointestinal toxicity in mice. Radiat Res, 100(1), 157-70.
  34. Lehman CM, Stewart JR (1983 Dec). In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor. Radiat Res, 96(3), 628-34.
  35. Stewart JR, Gibbs FA Jr, Lehman CM, Peck JW, Egger MJ (1983 Feb). Change in the in vivo hyperthermic response resulting from the metabolic effects of temporary vascular occlusion. Int J Radiat Oncol Biol Phys, 9(2), 197-201.

Review

  1. Blaylock RC, Lehman CM (2011 Nov). Managing transfusion service quality. [Review]. Arch Pathol Lab Med, 135(11), 1415-24.
  2. Lehman CM, Frank EL (1/2009). Laboratory monitoring of heparin therapy: partial thromboplastin time or anti-Xa Assay? [Review]. Lab Med, 40(1), 47-51.
  3. Lehman CM, Rodgers GM (2001 Feb). To IRB or not to IRB? That is no longer the question. [Review]. Am J Clin Pathol, 115(2), 187-91.
  4. Lehman CM, Becker JL, Wilkinson DS (1996 Dec). Red cells and platelets. Modifications for special patients. [Review]. Clin Lab Med, 16(4), 781-95.

Edited Book

  1. Bennett, Lehman, Rodgers (Eds.) (). Laboratory Hemostasis: A Practical Guide for Pathologists. (2). New York: Springer.
  2. Bennett, S, Lehman, CM, Rodgers, GM (Eds.) (04/2007). Laboratory Hemostasis: A Practical Guide for Pathologists. New York: Springer.

Book Chapter

  1. Rodgers GM, Lehman CM (). Diagnostic Approach to Bleeding Disorders. In Greer, Arber,Glader, List, Means, Rodgers (Eds.), Wintrobe's Clinical Hematology (14th, pp. 1054-1068). Philadelphia: Wolters Kluwer.
  2. Blaylock RC, Lehman CM (). Coagulation Testing and Transfusion Medicine. In Bennett, Lehman, Rodgers (Eds.), Laboratory Hemostasis (2, pp. 183-199). New York: Springer.
  3. Lehman CM (). Testing for Acquired Platelet Disorders. In Bennett, Lehman, Rodgers (Eds.), Laboratory Hemostasis (2, pp. 99-110). New York: Springer.
  4. Rodgers GM, Lehman CM (). Hemostasis Screening Assays. In Bennett, Lehman, Rodgers (Eds.), Laboratory Hemostasis (2, pp. 69-81). New York: Springer.
  5. Lehman CM (). Instrumentation for the Coagulation Laboratory. In Bennett, Lehman, Rodgers (Eds.), Laboratory Hemostasis (2, pp. 33-43). New York: Springer.
  6. Rodgers GM, Lehman CM (). Diagnostic Approach to the Bleeding Disorders. In Wintrobe's Clinical Hematology (13th).
  7. Rodgers GM, Lehman CM (12/2008). Diagnostic Approach to the Bleeding Disorders. In Greer JP, Foerster F, Rodger GM, Paraskeva F, Glader B, Arber DA, Means RT (Eds.), Wintrobe's Clinical Hematology (12, 2, pp. 1273-1288). New York: Lippincott Williams & Wilkins.
  8. Blaylock RC, LehmanCM (4/2007). Coagulation Testing and Transfusion Medicine. In Bennett ST; Lehman CM; Rodgers GM (Ed.), Laboratory Hemostasis: A Practical Guide for Pathologists (1, 1, pp. 207-225). New York: Springer.
  9. Rodgers GM, Lehman CM (4/2007). Hemostasis Screening Assays. In Bennett ST; Lehman CM; Rodgers GM (Ed.), Laboratory Hemostasis: A Practical Guide for Pathologists (1, 1, pp. 85-101). New York: Springer.
  10. Lehman CM (4/2007). Testing for Acquired Platelet Disorders. In Bennett ST; Lehman CM; Rodgers GM (Ed.), Laboratory Hemostasis: A Practical Guide for Pathologists (1, 1, pp. 121-136). New York: Springer.
  11. Lehman CM, Thompson C (4/2007). Instrumentation for the Coagulation Laboratory. In Bennett, S; Lehman CM; Rodgers GM (Eds.), Laboratory Hemostasis: A Practical Guide for Pathologists (1, 1, pp. 41-56). New York: Springer.

Commentary

  1. Lehman CM, Burgener R, Munoz O (). Autoverification and Laboratory Quality. Critical Values, 2(4), 24-27.

Case Report

  1. Knoblock RJ, Lehman CM, Smith RA, Apple FS, Roberts WL (2002 May). False-positive AxSYM cardiac troponin I results in a 53-year-old woman. Arch Path, 126(5), 606-9.

Editorial

  1. Lehman CM (). The Cool Factor. Point of Care, 14(4), 137.

Letter

  1. Lehman CM, Rodgers GM (2015 Apr). Utility of ADAMTS13 assays in diagnosing thrombotic thrombocytopenic purpura [Letter to the editor]. Arch Pathol Lab Med, 139(4), 433.
  2. Johnson-Davis KL, Thompson CD, McMillin GA, Lehman CM (). High amphetamine/methamphetamine concentrations in urine can cause error codes on the Ortho Vitros® fusion 5,1 fs automated chemistry analyzer [Letter to the editor]. J Anal Toxicol, 34(9), 607-8.

Abstract

  1. Furtado LV, Lehman CM, Thompson C, Wislon A, Grenache DG (). Can the qualitative point of care serum pregnancy test be considered obsolete? [Abstract]. Point of Care, 9(3), 138-9.
  2. Greene DN, Carlisle H, Clark CJ, Thompson CD, Lehman CM, McMillin GA (). Drugs of Abuse: detection in a cup [Abstract]. Clinical Chemistry, 56(6), A162-3.
  3. Thompson CD, Clark CJ, McMillin GA, Lehman CM, Johnson-Davis KL (). Evaluation of two chemistry analyzers for urine drug testing in the emergency department [Abstract]. Clinical Chemistry, 56(6), A238.
  4. Munoz O, Lehman CM (10-2009). Assessing the utility of repeating hematologic critical and delta check results [Abstract]. Am J Clin Pathol, 132(4), 639.
  5. Munoz O, Lehman CM (06/01/2008). Efficiency in the Hematology Laboratory [Abstract]. Int J Lab Hematol, 30, 914.
  6. Tandar A, Lehman CM, Rodgers GM, et al (2006). Should anticoagulation be used during routine diagnostic coronary angiography [Abstract]. J Am Coll Card, 47(4), 365A.
  7. Chakravarthy SB, Markewitz BA, Lehman CM (2005). Accuracy of Glucose Measurements in Critically Ill Patients in Shock [Abstract]. Chest Meeting Abstracts, 220S.
  8. Chakravarthy SB, Markewitz BA, LehmanCM (2005). Glucose Determination from Different Vascular Compartments in Critically ill Patients in Shock [Abstract]. Chest Meeting Abstracts, 128, 220S.
  9. Rettmann JA, Markewitz BA, Wilson LW, Mayer J, Lehman CM (2004). Concordance of the activated Partial Thromboplastin Time and the Anti-activated Factor X Assay in Monitoring Unfractionated Heparin Therapy in Critically Ill Patients [Abstract]. Chest Meeting Abstracts, 128, 220S.
  10. Markewitz B, Rettmen JA, Wilson LW, Lehman CM (2004). Anti-activated factor X heparin assays in critically ill patients with antithrombin deficiency [Abstract]. Chest Meeting Abstracts, 126, 875S-b-876S-b.
  11. Lehman CM, Wilson LW, Rodgers GM (2003). Performance Characteristics of a D-dimer Assay for the Diagnosis of DIC [Abstract]. Blood, 102(suppl), 1.
  12. Knoblock RJ, Smith RA, Lehman CM, Roberts WL (2001). An immunologic interference in the AxSYM troponin I assay [Abstract]. Am J Clin Pathol, 116(2), 278.
  13. Wilson LW, Fontenot JD, Lehman CM (2001). Evaluation of the Bayer ADVIA 120 hematology analyzer [Abstract]. Clin Chem, 47, A172.
  14. Lehman CM, Rodgers GM (2000). Abolition of the bleeding time test at an academic medical center [Abstract]. Blood, 96(suppl), 1.
  15. Coleman LW, Huggins F, Lehman CM, Roberts WL (2000). Analytical performance of a troponin I asay [Abstract]. Am J Clin Pathol, 114(42), 310.
  16. Huggins FL, Nielsen LG, Hastings MK, Blaylock RC, Lehman CM (1999). Lot to lot variation in analyte recovery on the Vitros 950 [Abstract]. Clin. Chem, 45, A3-A4.
  17. Becker JL, Jesse JK, Lehman CM (1996). Treatment of TTP using cryopoor plasma [Abstract]. J. Clin. Apher, 11, 109.
  18. Alcorn K, Lehman C, Kinder H, Edwards R, Yanovich S (1996). CD34 positive cell selection and T cell depletion of peripheral blood stem cell collections: a comparison of the Baxter Isolex 300SA and 300I systems [Abstract]. Blood, 88(suppl), 244b.
  19. Ben-Ezra J, Lehman CM (1996). Tranfusion of hemoglobin C-containing blood into sickle cell patients due to the selection of random African-American donor units to reduce red blood cell alloimmunization [Abstract]. Blood, 88(suppl), 185a.
  20. Goggins WC, Fisher RA, Cohen DS, Wolfe L, Kimball PM, Lehman CM, Ham JM, Posner MP (1995). Therapeutic plasmapheresis in liver transplantation for antibody mediated allograft dysfunction [Abstract]. Joint Congress on Liver Transplantation.
  21. Kimble P, Rhodes C, King A, Fisher B, Ham J, Lehman C, Posner M, Lee HM (1995). IgG positive flow crossmatches identify patients at risk for early elaboration of cytotoxic antibodies [Abstract]. The American Society of Transplant Physicians Meeting.
  22. Ben-Ezra J, Lehman C, Fisher L (1993). Normalization of MPV and PDW values trail the improvement of platelet counts in patients being treated for TTP [Abstract]. Blood, 82(suppl), 602a.
  23. Lehman CM, Comerford J, Nasim S, Karcher D, Sarago C, Garrett CT (1992). Use of the polymerase chain reaction for detection of immunoglobulin heavy chain gene rearrangements and minimal residual B-Cell neoplasia [Abstract]. Am J Clin Pathol, 97, 443.
  24. Comerford J, Lehman CM, Nasim S, Karcher D, Sarago C, Garrett CT (1991). Use of nested polymerase chain reaction in detection of lymphoproliferative disease [Abstract]. Am J Clin Pathol, 96, 426.
  25. Comerford J, Lehman CM, Nasim S, Karcher D, Sarago C, Garrett CT (1991). Use of nested polymerase chain reaction in detection of lymphoproliferative disease [Abstract]. Am J Clin Pathol, 96, 426.
  26. Lehman CM, Dethlefsen LA (1988). Energy state and radiation response of proliferating versus quiescent murine tumor cells [Abstract]. Radiation Research Meeting.
  27. Dethlefsen LA, Lehman CM, Peck VM (1985). Effects of acute glutathione depletion by buthionine sulfoximine plus dimethylfumarate on 66 murine mammary carcinoma cells In Vitro [Abstract]. Radiation Research Meeting.
  28. Lehman CM, Wallen CA, Stewart JR (1984). The effect of prolonged vascular occlusion on the radiation response of RIF-1 tumors [Abstract]. Radiation Research Meeting.
  29. Dethlefsen LA, Riley RM, Lehman CM (1983). Late effects of Adriamycin plus x-irradiation on the murine intestine [Abstract]. International Radiation Research Meeting.
  30. Lehman CM, Broom AD, Hunter R, Stewart JR (1983). Effect of hyperthermia on cellular and systemic toxicity of Misonidazole: some pharmacokinetic considerations [Abstract]. Radiat Res, 94, 588.
  31. Stewart JR, Lehman CM, Pack WL (1982). In Vivo cytotoxicity of Misonidazole and hyperthermia in a transplanted mouse mammary tumor [Abstract]. Radiat Res, 91, 322.

Report

  1. Karcher DS, Lehman CM (). QP-114 Clinical Cosequences of Specimen Rejection. Wayne: Clinical and Laboratory Standards institute.
  2. Budd JR, De Vore K, Hawkins DM, Parvin CA, Lehman CM (). C54-A-IR: Verification of Comparability of Patient Results Within One Health Care System. Wayne, PA: Clinical and Laboratory Standards Institute.
  3. Alcorn KW, Ramsey GE, Lehman CM (). QP 112 Appropriateness of Plasma Transfusions. Wayne: Clinical and Laboratory Standards Institute.
  4. Lehman CM, Howanitz PJ, Karcher DS (). QP102 Utility of Repeat Testing of Critical Values. Chicago: CAP.
  5. Lehman CM Grimm E, Ramsey G (12-2009). QP093 Quality of Transfusion Documentation (QP093). Chicago: CAP.
  6. Lehman CM, Wagar EA, Grimm EE, Friedberg RC (12/08). QP083 Utilization of Red Blood Cell Transfusions (QP083). Chicago: College of American Pathologists.
  7. Lehman CM, Friedberg, RC, Wilkinson DS, AuBuchon JP (04/18/2008). QP074 Blood Bank Safety Practices (QP074). Chicago: College of American Pathologists.
  8. Lehman CM, Bennett S, Astles JR, et al (05/30/2008). Verification of Comparability of Patient Results Within One Healthcare System (CLSI document C54-A). Clinical and Laboratory Standards Institute.
  9. Blonshine S, Fallon KD, Lehman CM, Sittig S (09/20/2004). Clinical and Laboratory Standards Institute. Procedures for the Collection of Arterial Blood Specimens; Approved Standard-Fourth Edition. NCCLS document H11-A4.

Video/Film/CD/Web/Podcast

  1. Lehman CM (). Hemolysis holdup. AHRQ WebM&M [serial online] [Web].

Site Links

  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • The Imagine Perfect Care Program

Helpful Links

  • Referring Providers
  • Find an Interpreter
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2018 University of Utah Health